Arkolith/Insider Trading/MIRM/Form 4

Peetz Christopher

CHIEF EXECUTIVE OFFICER, DirectorMirum Pharmaceuticals, Inc. (MIRM) · full profile →Form 4 · filed Jan 30, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 28, 2026Grant(A)75K—$075K
Jan 28, 2026Grant(A)44K—$044K
Jan 28, 2026Grant(A)67K—$067K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001614740-26-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML